A detailed history of Bokf, Na transactions in Incyte Corp stock. As of the latest transaction made, Bokf, Na holds 11 shares of INCY stock, worth $765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 9 22.22%
Holding current value
$765
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $114 - $137
2 Added 22.22%
11 $0
Q2 2024

Aug 07, 2024

BUY
$51.18 - $63.75 $102 - $127
2 Added 28.57%
9 $0
Q1 2024

May 15, 2024

SELL
$56.55 - $66.59 $452 - $532
-8 Reduced 53.33%
7 $0
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $782 - $962
15 New
15 $0
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $15,942 - $19,524
227 New
227 $16,000
Q1 2021

Apr 21, 2021

SELL
$76.02 - $100.5 $514,047 - $679,581
-6,762 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $486,781 - $589,033
-6,029 Reduced 47.13%
6,762 $589,000
Q3 2020

Oct 30, 2020

SELL
$85.07 - $109.69 $20,842 - $26,874
-245 Reduced 1.88%
12,791 $1.15 Million
Q2 2020

Aug 12, 2020

BUY
$74.18 - $108.93 $420,303 - $617,197
5,666 Added 76.88%
13,036 $1.36 Million
Q1 2020

May 13, 2020

BUY
$63.18 - $85.97 $465,636 - $633,598
7,370 New
7,370 $540,000
Q2 2018

Aug 13, 2018

SELL
$60.85 - $83.98 $216,869 - $299,304
-3,564 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $296,025 - $359,892
3,564 New
3,564 $298,000
Q3 2017

Nov 14, 2017

SELL
$109.15 - $138.27 $161,323 - $204,363
-1,478 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,478
1,478 $186,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.